FDA — authorised 8 January 2015
- Application: NDA206316
- Marketing authorisation holder: DAIICHI SANKYO INC
- Local brand name: SAVAYSA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Savaysa in United States
FDA authorised Savaysa on 8 January 2015
Marketing authorisation
Savaysa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Savaysa approved in United States?
Yes. FDA authorised it on 8 January 2015.
Who is the marketing authorisation holder for Savaysa in United States?
DAIICHI SANKYO INC holds the US marketing authorisation.